The AHSN Network’s real-world evaluation programme aims to help innovators work with adopting organisations to secure the rapid rollout of new products.

The AHSN Network aims to ensure that innovators perform high-quality, relevant real-world evaluations that:

  • demonstrate the value of a new product in real-world settings (outside of a controlled research environment)
  • help organisations to implement new technology as easily as possible by building on learnings from previous rollouts in other organisations.

Read the AHSN Network guide: Real-World Evaluation to facilitate adoption at scale.

Some AHSNs have an ‘in-house’ ability to deliver this work, but many work with providers in the academic and private sectors to offer this service.

If you have an innovation that you believe can improve outcomes for patients in the UK and would like advice on conducting real-world evaluations, contact your local AHSN.

  • Collaborating to improve access and equity of care for sickle cell sufferers

    Harriet Smith is the Health Innovation Network's MTFM National Lead for Spectra Optia. In this blog, she outlines the collaborative efforts to improve the support available to people with sickle cell disease, and tackle long standing inequalities. Sickle cell disease (SCD) is a serious and lifelong health condition. People with SCD produce unusually shaped red [...]

  • Until tackling health inequalities becomes business as usual, innovation is our best chance of equity

    Dr Stuart Monk, National Programme Director for the Accelerated Access Collaborative (AAC) Programmes at the Health Innovation Network, talks about the pivotal role of innovation tackling healthcare inequalities in the NHS. At the Royal Society of Medicine’s Tackling Inequalities conference it was clear from the passion in the room that great progress has been made [...]

  • Where health innovation is concerned, 15 approaches are better than one

    Dr Phil Jennings, Vice Chair of the Health Innovation Network and Chief Executive of Health Innovation North West Coast, discusses why the Network’s collective relicensing gives innovation a better chance of success. In any one day in England, 1.2 million people attend a GP appointment, over a quarter of a million people have an outpatient [...]